Proliferative responses to recall antigens are associated with pregnancy outcome in women with a history of recurrent spontaneous abortion.
Open Access
- 15 September 1997
- journal article
- clinical trial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 100 (6) , 1330-1334
- https://doi.org/10.1172/jci119652
Abstract
Maternal tolerance of the fetal hemiallograft suggests that immunomodulation occurs during gestation. Therefore, recurrent spontaneous abortion (RSA) may represent a failure of the immune changes that maintain pregnancy. We hypothesized that fertile women but not women with RSA may lose their immune responses to recall antigens when pregnant. This phenomenon has been seen in immunosuppressed transplant recipients and is associated with graft survival. Therefore, we evaluated proliferative responses to recall antigens in four groups of women: group 1, nonpregnant fertile women with no history of pregnancy loss and at least one prior healthy pregnancy, n = 13; group 2, nonpregnant women with a history of three or more spontaneous abortions, n = 28; group 3, healthy pregnant women between 6 and 9 wk of gestation without a history of prior pregnancy loss, n = 15; and group 4, pregnant women between 6 and 9 wk of gestation, with a history of RSA, n = 22. Proliferative responses of peripheral blood leukocytes to the recall antigens influenza and tetanus, alloantigens, and phytohemagglutinin were determined prospectively. Positive responses (stimulation index > 3) to recall antigens (a response to either influenza or tetanus was considered positive) were as follows: group 1 (nonpregnant fertile women), 11/13 (85%); group 2 (nonpregnant RSA women), 24/28 (86%); group 3 (pregnant fertile women), 4/15 (27%) (P </= 0.007); and group 4 (pregnant RSA women), 13/22 (59%) (P = 0.032) [corrected]. In group 4, there was 100% fetal survival in the nine women who lost responsiveness to recall antigens; however, in the 13/22 patients who responded to recall antigens, 9/13 (69%) had a repeat spontaneous abortion. These findings suggest that immunosuppression, indirectly measured by proliferation to recall antigens, is necessary for early pregnancy maintenance. Furthermore, this approach may be useful for predicting pregnancy outcome for women with RSA and may provide a useful means for designing and monitoring therapies.Keywords
This publication has 23 references indexed in Scilit:
- Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancyClinical and Experimental Immunology, 1996
- Maternal–fetal immunology and autoimmune disease. Is some autoimmune disease auto‐alloimmune or allo‐autoimmune?Arthritis & Rheumatism, 1996
- CD4+ Lymphocytes in Perinatal Human Immunodeficiency Virus (HIV) Infection: Evidence for Pregnancy-Induced Immune Depression in Uninfected and HIV-Infeeted WomenThe Journal of Infectious Diseases, 1995
- T Cell Awareness of Paternal Alloantigens During PregnancyScience, 1995
- Cytokine production and visualized effects in the feto-maternal unit. Quantitative and topographic data on cytokines during intrauterine disease.1995
- T-Helper 1-Type Immunity to Trophoblast in Women With Recurrent Spontaneous AbortionJAMA, 1995
- THE THERAPEUTIC EFFECTS OF AN ENGINEERED HUMAN ANTI-TUMOUR NECROSIS FACTOR ALPHA ANTIBODY (CDP571) IN RHEUMATOID ARTHRITISRheumatology, 1995
- Fertility Among Women With Recurrent Spontaneous Abortions—The Effect of Paternal Cell Immunization TreatmentAmerican Journal of Reproductive Immunology, 1995
- T helper cell dysfunction in systemic lupus erythematosus (SLE): Relation to disease activityJournal of Clinical Immunology, 1994
- Value of in vitro CD4+ T helper cell function test for predicting long-term loss of human renal allografts.1994